Bid to delay three-week AFT Pharmaceuticals trial declined

Bid to delay three-week AFT Pharmaceuticals trial declined
AFT Pharmaceuticals' managing director Hartley Atkinson is claiming PBL Solutions is taking against the NZX-listed company. (Image: Supplied)
Riley Kennedy
AFT Pharmaceuticals will face off against a former joint venture partner after the high court rejected a bid to delay the dispute's hearing until 2024.In the high court at Auckland, Justice Geoffrey Venning affirmed a three-week hearing between AFT and British Virgin Islands-based PBL Solutions will take place in October this year, bringing their two-year-old dispute to a head. PBL sought to have the case pushed out by 12 months, although the courts wouldn't have been able to hear it before 2024.While the judge rejected the applica...

More Markets

Australian shares rally as dollar hits six-month high
Markets Aus Market Wrap

Australian shares rally as dollar hits six-month high

The ASX200 has risen 1.2% to hit a nine-day high.

AAP 7:45am
NZ sharemarket down, Oz and US stocks climb
Markets Market close

NZ sharemarket down, Oz and US stocks climb

The S&P/NZX 50 Index closed at 11,746.66, down 44.26 points or 0.38%.

Graham Skellern 04 Jul 2024
Summerset anticipates flat 1H underlying profit
Markets

Summerset anticipates flat 1H underlying profit

The company is NZ's best-performing retirement village operator.

Gregor Thompson 04 Jul 2024
Infratil's CDC investment cracks $5 billion mark
Markets

Infratil's CDC investment cracks $5 billion mark

Surging datacentre demand and expanded development plans benefit Infratil.